Auranofin inhibits histamine release from rat peritoneal mast cells
- 1 January 1990
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 12 (4) , 403-407
- https://doi.org/10.1016/0192-0561(90)90022-f
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- An open study of Auranofin in the treatment of steroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1988
- Chrysotherapy in the treatment of corticosteroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1987
- Auranofin modulates mast cell histamine and polymorphonuclear leukocyte collagenase releaseInflammation Research, 1986
- Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofinInflammation Research, 1986
- Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophilsJournal of Allergy and Clinical Immunology, 1984
- Inhibition by disodium cromoglycate of anaphylactic histamine secretion from rat peritoneal mast cells in the presence of phosphatidylserineInflammation Research, 1983
- Modulation of Neutrophil Functions by AuranofinScandinavian Journal of Rheumatology, 1983
- Management of rheumatoid arthritis with oral goldArthritis & Rheumatism, 1979
- Studies on the Mechanism of Tachyphylaxis to Disodium CromoglycateInternational Archives of Allergy and Immunology, 1977
- Tissue gold levels after chrysotherapy.Annals of the Rheumatic Diseases, 1974